KaydedilenlerDerginizi ekleyin

Dergiler / Erciyes Medical Journal / 2022 / Cilt: 44 - Sayı: 1

A Recent History of Ultrasound Contrast Media and Nuclear Medicine Tracers

Bruno BONNEMAİN
Sayfa
116–120
Yayın Tarihi
2022-10-11
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

As for other imaging techniques, however, a significant slowdown in innovation was observed because of the difficulties associated with applications for the marketing authorization of diagnostic imaging products and the low return on investment for the concerned manufacturers.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The recent developmental history of contrast media and nuclear medicine tracers has been crucial in facilitating the innovation of radiology equipment.
📊
Temel Bulgular & Veri:However, the revolution in nuclear medicine arrived with the use of positron emission tomography with Fluorine-18 fluorodeoxyglucose (18F-FDG) in this field, followed by new and numerous other products and radioelements such as gallium-68 and the corresponding generators.
💡
Sonuç & Katkı:As for other imaging techniques, however, a significant slowdown in innovation was observed because of the difficulties associated with applications for the marketing authorization of diagnostic imaging products and the low return on investment for the concerned manufacturers.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

The recent developmental history of contrast media and nuclear medicine tracers has been crucial in facilitating the innovation of radiology equipment. Modern ultrasound has provided an opportunity for developing gas-encapsulated contrast products. In addition, scintigraphy has also evolved with “technetium cows,” especially in cardiology. However, the revolution in nuclear medicine arrived with the use of positron emission tomography with Fluorine-18 fluorodeoxyglucose (18F-FDG) in this field, followed by new and numerous other products and radioelements such as gallium-68 and the corresponding generators. To highlight the lesser known history of ultrasound contrast media and nuclear medicine tracers, this review indicates the success of its progress over the last decades, at least at the university level. It has enabled radiological practices to evolve and accompany the technological innovations in imaging equipment. In all fields, patients have been able to benefit from the knowledge acquired for improving the diagnosis and therapeutic management of their pathologies. As for other imaging techniques, however, a significant slowdown in innovation was observed because of the difficulties associated with applications for the marketing authorization of diagnostic imaging products and the low return on investment for the concerned manufacturers.

🔖

Bu Makaleye Atıf Yap

BONNEMAİN, B. (2022). A Recent History of Ultrasound Contrast Media and Nuclear Medicine Tracers. Erciyes Medical Journal, Cilt: 44 - Sayı: 1, 116–120. https://ajindex.com/articles/502161

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (18)

  1. Thomas AMK, Banerjee AK. The history of radiology. Oxford: Oxford University Press; 2013
  2. Bonnemain B. History of contrast media: celebrating the centenary of the use of Lipiodol in radiology. Erciyes Med J 2021, June 1. • DOI: 10.14744/etd.2021.76429. [Ahead of Print]
  3. Newman PG, Rozycki GS. The history of ultrasound. Surg Clin North Am 1998; 78(2): 179–95
  4. Scatliff JH, Morris PJ. From Roentgen to magnetic resonance imaging: the history of medical imaging. N C Med J 2014; 75(2): 111–3
  5. Patton JA, Townsend DW, Hutton BF. Hybrid imaging technology: from dreams and vision to clinical devices. Semin Nucl Med 2009; 39(4): 247–63
  6. Gramiak R, Shah PM. Echocardiography of the aortic root. Invest Radiol 1968; 3(5): 356–66
  7. Smith MD, Kwan OL, Reiser HJ, DeMaria AN. Superior intensity and reproducibility of SHU-454, a new right heart contrast agent. J Am Coll Cardiol 1984; 3(4): 992–8
  8. Nanda NC. History of echocardiographic contrast agents. Clin Cardiol 1997; 20(10 Suppl 1): I7–I11
  9. Quay SC, Eisenfeld AJ. Safety assessment of the use of perflenapent emulsion for contrast enhancement of echocardiography and diagnostic radiology ultrasound studies. Clin Cardiol 1997; 20(10 Suppl 1): I19–I26
  10. Mattrey RF. Ultrasound contrast media: past, present, and future. In: Thomsen HS, Muller RN, Mattrey RF, editors. Trends in contrast media. Berlin: Springer Verlag; 1999
  11. Kasprzak JD, Ten Cate FJ. New ultrasound contrast agents for left ventricular and myocardial opacification. Herz 1998; 23(8): 474–82
  12. Rafailidis V, Huang DY, Yusuf GT, Sidhu PS. General principles and overview of vascular contrast-enhanced ultrasonography. Ultrasonography 2020; 39(1): 22–42
  13. Yang H, Cai W, Xu L, Lv X, Qiao Y, Li P, et al. Nanobubble-Affibody: Novel ultrasound contrast agents for targeted molecular ultrasound imaging of tumor. Biomaterials 2015; 37: 279–88
  14. Wang S, Hossack JA, Klibanov AL. Targeting of microbubbles: contrast agents for ultrasound molecular imaging. J Drug Target 2018; 26(5-6): 420–34
  15. Strauss HW, Zaret B, Pieri G, Lahiri A. History corner: Antoine Henri Becquerel. J Nucl Cardiol 2017; 24(5): 1515–6
  16. Kyle RA, Shampo MA. Irene Curie and her husband Frederic Joliot. JAMA 1974; 227(8): 906
  17. Creager ANH. Life Atomic: A history of radioisotopes in science and medicine. Chicago: University of Chicago Press; 2013
  18. Sawin CT, Becker DV. Radioiodine and the treatment of hyperthyroidism: the early history. Thyroid 1997; 7(2): 163–